The 7 closest competitors and alternatives to Immusoft Corp among drug discovery companies — ranked by similarity to what Immusoft Corp actually does, not by market-cap band.
Subscribe to see Immusoft Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Immusoft Corp. is based in Seattle, Washington, and operates as a corporate entity engaged in technical research and business operations.
Immusoft Corp is a drug discovery company headquartered in United States. Its most recent funding round raised $4.6M in May 2024. Xcout tracks 9 named people at Immusoft Corp, including Sean Ainsworth (Chief Executive Officer and Chairman of the Board).
3 more named people on record for Immusoft Corp, with roles, board committees and tenure — see the full roster →
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.6M | — | |
| SEC Form D filing | $10.3M | — | |
| Series B | $20M | — | |
| SEC Form D filing | $3.6M | — | |
| Series B | $20.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Immusoft Corp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharmaceuticals
Alpine Immune Sciences, Inc. is a publicly traded clinical-stage biopharmaceutical company founded in 2015. Headquartered in Seattle, Washington, the company focuses on discovering and developing innovative immunotherapies.
Similar drug discovery company
Cyrus Biotechnology, Inc. is a biotechnology company with a corporate office located on 2nd Avenue in Seattle, Washington, United States. The firm provides advanced computational biology software and services.
Similar drug discovery company
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Biopharmaceuticals
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.
Accelerator
Accelerator Corp. serves as a vehicle for capital-efficient investment in and management of emerging biotechnology opportunities within the Greater Seattle innovation ecosystem.
Bioscience Research
The Allen Institute is a non-profit biomedical research organization that conducts large-scale, open-science initiatives focused on brain science, cell science, immunology, and synthetic biology.
Biology
NanoString Technologies develops life science tools such as the nCounter Analysis System and GeoMx Digital Spatial Profiler, with primary locations in Seattle and Bothell, Washington.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Immusoft Corpand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →